This is a non-core endpoint: only basic statistics are computed.
Localized swelling, mass and lump of skin and subcutaneous tissue
R18_LOCALIZED_SWELL_MASS_LUMP_SKIN_SUBCU_TISSUE
No definition available.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
10501
Check minimum number of events None
10501
Include endpoints None
10501
Remove individuals based on genotype QC
10103
R18_LOCALIZED_SWELL_MASS_LUMP_SKIN_SUBCU_TISSUE
Control definitions
Control exclude
R18_SYMPTOMS_SIGNS_INVOLVI_SKIN_SUBCU_TISSUE
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
R2[0-3]
Name in latin
Intumescentia localis, massa sive nodus cutis sive telae subcutaneae
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Localized swelling, mass and lump of skin and subcutaneous tissue
based on the number of shared cases.
Broader endpoints:
- Symptoms and signs involving the skin and subcutaneous tissue
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
- Any ICDMAIN event in hilmo or causes of death
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 10103 | 5794 | 4309 |
| Unadjusted prevalence (%) | 2.68 | 2.75 | 2.59 |
| Mean age at first event (years) | 55.77 | 53.13 | 59.33 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: R18_LOCALIZED_SWELL_MASS_LUMP_SKIN_SUBCU_TISSUE – Localized swelling, mass and lump of skin and subcutaneous tissue
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Localized swelling, mass and lump of skin and subcutaneous tissue
↥Endpoint not on priority list, no data to show.